Increasing incidence of infectious diseases and cancer. Technological advancements in rapid microbiology testing. Increased focus on the early detection of infectious diseases. The report “Rapid ...

Advanced biologics and patient-specific therapies reduce opportunities for terminal sterilization, elevating proactive microbial risk control and integrating QC microbiology into CCS authorship, risk ...

Researchers and therapeutic manufacturers have long relied on classical microbiological methods to check their samples and surfaces for microbial contamination, primarily using lengthy ...

The bioburden testing market presents opportunities driven by stringent regulations and the need for contamination control in ...